Clinical Trial Update: A Two-Part Infant Study for Early Diagnosis of Respiratory Syncytial Virus (RSV) and Evaluation of JNJ-53718678 in RSV Acute Respiratory Tract Disease [Phase 2]

View source ↗

Summary

A Phase 2 infant study evaluated early diagnosis of Respiratory Syncytial Virus and the evaluation of JNJ-53718678 in RSV acute respiratory tract disease; the t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syncytial Virus Infection

Drugs mentioned

• JNJ-53718678

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Respiratory Syncytial Viruses | Phase 2 | Status: COMPLETED | Results posted: 2022-06-08